Scrub Typhus Involving Central Nervous System, India, 2004–2006 by Mahajan, Sanjay K. et al.
LETTERS
Scrub Typhus 
Involving Central 
Nervous System, 
India, 2004–2006
To the Editor: Scrub typhus, 
caused by Orientia tsutsugamushi, is 
one of the most common infectious 
diseases of rural southern Asia, south-
eastern Asia, and the western Paciﬁ  c. 
The disease is transmitted to humans 
by the bite of larvae of trombiculid 
mites harboring the pathogen. The 
disease often appears as a nonspeciﬁ  c 
febrile illness. The clinical picture of 
scrub typhus is typically associated 
with fever, rash, myalgia, and dif-
fuse lymphadenopathy (1). Immuno-
ﬂ  uorescence assay (IFA) is the test of 
choice for serodiagnosis of rickettsial 
diseases (2). Scrub typhus has been 
reported from northern, eastern, and 
southern India, and its presence has 
been documented in at least 11 Indian 
states (3–7).
Our study’s goal was to retro-
spectively analyze data of patients 
with scrub typhus involving the cen-
tral nervous system. Scrub typhus was 
suspected on the basis of clinical signs 
such as febrile illness or fever with 
rash or eschar. The fever workup pro-
ﬁ  le (Widal agglutination test, periph-
eral smear, blood, and urine culture) 
was noncontributory. Blood samples 
were obtained after patients gave in-
formed consent. All patients with clin-
ically suspected scrub typhus received 
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Table. Clinical features and laboratory investigations of patients who had scrub typhus with central nervous system involvement, India, 
2004–2006* 
Clinical and laboratory features 
Results
Patient 1  Patient 2  Patient 3  Patient 4 
Age, y/sex  52/M 50/F  30/F  47/F 
Date of hospital admission  2004 Aug 22  2004 Aug 30  2005 Sep 9  2005 Sep 15 
Fever duration before admission, d†  12 12 9 16
Chills   + + + 
Rigors + + + 
Headache   + + + 
Myalgia   + + + +
Abdominal pain  + + 
Seizure  ++
Altered sensorium + + + +
Conjunctival suffusion  +  ++
Jaundice + + + +
Eschar   + Axilla  
Lymphadenopathy   + Generalized  + Cervical  + Cervical  
Meningeal signs  + + + +
Urea, mg/dL  104 96 84 143
Creatinine, mg/dL  3.9 1.5 1.6 2.7
Bilirubin, mg/dL 
 Total  3.5 2.7 4.6 3.0
 Conjugated  1.0 1.7 3.6 2.6
Aspartate aminotransferase, IU  167 160 166 30
Alanine aminotransferase, IU  139 198 185 38
Alkaline phosphatase, IU  80 1,000  1,000  782
Proteinuria, mg/dL  +  ++
CSF cytology  Lymphocytes,  
54 cells/mm
3
Lymphocytes,  
14 cells/mm
3
Lymphocytes,  
60 cells/mm
3
Neutrophils,
38 cells/mm
3
Protein, mg/dL   125 69 34 118
Glucose, mg/dL  34 44 33 48
IFA titers‡ 
  IgG  512 512 Not done  Not done 
 IgM  <64 <64
Drug treatment  Azithromycin, 
doxycycline 
Ceftriaxone,
doxycycline 
Ceftriaxone,
doxycycline 
Ceftriaxone,
doxycycline 
Outcome     Died Improved  Improved  Left hospital 
against advice 
*CSF, cerebrospinal fluid; IFA, immunofluorescence assay; Ig, immunoglobulin. 
†Fever defined as AM temperature >98.9
oF or PM temperature >99.9
oF.
‡IFA significant titers: IgG >128; IgM >64. The single serum samples, obtained at admission to hospital, were subjected to IFA by using a panel of 11 
rickettsial antigens comprising spotted fever group rickettsiae (Rickettsia japonica, R. helvetica, R. slovaca, R. conorii subsp. indica, R. honeï, R. 
heilongjangensis, and R. felis), R. typhi, and Orientia tsutsugamushi (Gilliam, Kato, and Kawasaki strains). LETTERS
antirickettsial drugs (doxycycline and/
or azithromycin) empirically. IFA and 
PCR of blood samples were performed 
to conﬁ   rm scrub typhus following 
standard protocol (3). DNA was ex-
tracted from the blood sample (buffy 
coat) by using QIAamp DNA Mini Kit 
(QIAGEN GmbH, Hilden, Germany) 
according to the manufacturer’s in-
structions. A standard PCR speciﬁ  c 
for the 56-kDa protein with forward 
and reverse primers (OtsuF: 5′-
AATTGCTAGTGCAATGTCTG-3′ 
and OtsuR: 5′-GGCATTATAGTAGGC
TGAG-3′) was performed (3). PCR 
products were puriﬁ   ed by using the 
QIAquick PCR Puriﬁ  cation Kit (QIA-
GEN) according to the manufacturer’s 
instructions. Sequencing reactions 
were done by using a DNA sequenc-
ing kit, dRhodamine Terminator Cycle 
Sequencing Ready Reaction Mix (Ap-
plied Biosystems, Foster City, CA, 
USA). Sequencing was performed on 
an ABI PRISM 310 DNA Sequencer 
(Applied Biosystems). The obtained 
sequences were identiﬁ  ed by compari-
son with sequences available in Gen-
Bank by using the BLAST software 
(http://blast.ncbi.nlm.nih.gov) (3).
During 2004–2006, scrub typhus 
was conﬁ  rmed in 27 patients; 4 had 
features of central nervous system 
involvement. All 4 had fever with al-
tered sensorium and meningeal signs; 
2 had seizures. No neurologic focal 
deﬁ  cit was noted, but all showed ce-
rebrospinal  ﬂ   uid abnormalities. One 
patient had an eschar, but none had 
a rash. Serum of 2 patients was sub-
jected to IFA; both samples showed 
high titers (Table), and PCR for blood 
was positive for O. tsutsugamushi for 
all patients. Serum was not subjected 
to examination for leptospirosis. Pa-
tients were treated mainly on the basis 
of clinical grounds because results of 
serology were not available immedi-
ately. Some clinical features of scrub 
typhus and leptospirosis are similar, 
and dual infections have been report-
ed (8); therefore, antimicrobial drugs 
active against both leptospirosis and 
scrub typhus were included in treat-
ment regimens. One patient received 
doxycycline and azithromycin, and the 
remaining 3 received ceftriaxone in 
addition to doxycycline. Two patients 
improved, 1 died, and 1 left hospital 
against medical advice. The clinical 
and laboratory details, treatments, and 
outcomes of all patients are given in 
the Table.
O. tsutsugamushi is an obligate 
intracellular parasite of professional 
and nonprofessional phagocytes that 
invades the central nervous system as 
part of systemic infection and is found 
in endothelial cells of blood vessels 
and in circulating phagocytes. A se-
vere headache occurs almost invari-
ably and has been used as a key clini-
cal criterion for identifying suspected 
cases. Severe features of central ner-
vous system involvement, such as 
neck stiffness, neurologic weakness, 
seizures, delirium, and coma, have 
been reported. Meningismus or men-
ingitis has been found in 5.7%–13.5% 
of patients (9). The greatest degree of 
central nervous system involvement 
in rickettsial diseases occurs in Rocky 
Mountain spotted fever and epidemic 
typhus, followed closely by scrub ty-
phus. The meninges are more com-
monly involved by O. tsutsugamushi 
than by other rickettsial infections, 
and the overall histologic picture in 
the central nervous system is best de-
scribed as a meningoencephalitis (9). 
An exhaustive study of 200 cases of 
scrub typhus showed central nervous 
system involvement in most patients. 
However, focal central nervous sys-
tem damage was rare, and during the 
encephalitis stage, few objective neu-
rologic signs were apparent, other than 
those suggesting more generalized ce-
rebral involvement, such as confusion, 
tremor, and restlessness (10).
Now that it is established that O. 
tsutsugamushi does invade cerebro-
spinal  ﬂ  uid, scrub typhus should be 
considered a cause of mononuclear 
meningitis in areas in which it is en-
demic. In our study 1 patient died 
despite treatment with doxycycline 
and azithromycin, suggesting the pos-
sibility of resistance to these antimi-
crobial drugs as recently posited in a 
study conducted in southern India (6). 
Scrub typhus in these regions should 
be further investigated in prospective 
studies, and clinical isolates should be 
obtained to evaluate susceptibility to 
antimicrobial drugs.
Sanjay K. Mahajan, 
Jean-Marc Rolain, Anil Kanga, 
and Didier Raoult
Author afﬁ   liations: Indira Gandhi Medical 
College, Shimla, India (S.K. Mahajan, A. 
Kanga); and Université de la Méditerranée, 
Marseille, France (J.-M. Rolain, D. Raoult)
DOI: 10.3201/eid1610.100456
References 
  1.   Raoult D. Scrub typhus. In: Mandell GL, 
Bennet JE, Dolin R, editors. Principles 
and practice of infectious diseases. 6th 
ed. Philadelphia: Churchill Livingstone; 
2004. p. 230–10.
  2.   Blacksell SD, Bryant NJ, Paris DH, Doust 
AJ, Sakoda Y, Day NPJ. Scrub typhus se-
rologic testing with indirect immunoﬂ  uo-
rescence method as a diagnostic gold stan-
dard: a lack of consensus leads to lot of 
confusion. Clin Infect Dis. 2007;44:391–
401. DOI: 10.1086/510585
  3.   Mahajan SK, Rolain JM, Kashyap R, Bak-
shi D, Sharma V, Prasher BS, et al. Scrub 
typhus in Himalayas. Emerg Infect Dis. 
2006;12:1590–2.
  4.   Mahajan SK, Kashyap R, Kanga A, Shar-
ma V, Prasher BS, Pal LS. Relevance of 
Weil-Felix test in diagnosis of scrub ty-
phus in India. J Assoc Physicians India. 
2006;54:619–21.    
  5.   Chaudhry D, Garg A, Singh I, Tandon C, 
Saini R. Rickettsial diseases in Haryana: 
not an uncommon entity. J Assoc Physi-
cians India. 2009;57:334–7.    
    6.   Mathai E, Rolain JM, Verghese GM, 
Abraham OC, Mathai D, Mathai M, et 
al. Outbreak of scrub typhus in southern 
India during the cooler months. Ann N Y 
Acad Sci. 2003;990:359–64.
  7.   Prabagaravarthanan R, Harish BN, Parija 
SC. Typhus fever in Pondicherry. J Com-
mun Dis. 2008;40:159–60.
    8.   Lee CH, Liu JW. Coinfection with 
leptospirosis and scrub typhus in Tai-
wanese patients. Am J Trop Med Hyg. 
2007;77:525–7.
1642  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 10, October 2010LETTERS
    9.   Drevets DA, Leenen PJM, Greenﬁ  eld 
RA. Invasion of central nervous system 
by intracellular bacteria. Clin Microbiol 
Rev. 2004;17:323–47. DOI: 10.1128/
CMR.17.2.323-347.2004
10.   Kim DE, Lee SH, Park KI, Chang KH, 
Roh KH. Scrub typhus encephalomyelitis 
with prominent neurological signs. Arch 
Neurol. 2000;57:1770–2. DOI: 10.1001/
archneur.57.12.1770
 Address for correspondence: Sanjay K. Mahajan, 
25/3, US Club, Shimla, Himachal Pradesh, India 
171001; email: sanjay_mahajan64@rediffmail.
com
Pandemic (H1N1) 
2009 and HIV 
Co-infection
To the Editor: We report a case 
of pandemic (H1N1) 2009 infection 
in a man with serologic evidence of 
HIV-1 infection. The clinical course 
was complicated by lung and brain 
involvement (respiratory failure and 
lethargy), severe leukopenia, and 
thrombocytopenia, but complications 
resolved after treatment with oselta-
mivir (150 mg 2×/d).
In November 2009, a 47-year-old 
man who had received a diagnosis of 
hepatitis C infection 8 months earlier 
sought treatment at Ospedale Santa 
Maria Nuova, Reggio Emilia, Italy. He 
had a 3-day history of fever, dry cough, 
and drowsiness. Eight days before be-
ing admitted, the man had resided in 
the hospital’s inpatient detoxiﬁ  cation 
unit, in which at least 10 inﬂ  uenza-
like cases had been recorded. While in 
the detoxiﬁ  cation unit, he had received 
methadone, 50 mg 1×/d. Computed 
tomography images of the brain and 
radiographs of the chest were normal; 
ultrasound examination showed up-
per lobe consolidation of the left lung. 
Hematochemistry showed high cre-
atine phosphokinase levels, leukocyte 
count 1,380 cell/mm3 (reference range 
4,000–10,000 cells/mm3), thrombo-
cyte count 34,000 cells/mm3 (refer-
ence range 150,000–450,000 cells/
mm3), partial pressure of oxygen 56 
mm Hg, and partial pressure of carbon 
dioxide 53 mm Hg. Urinalysis results 
were negative for heroin, cocaine, and 
alcohol; cerebrospinal ﬂ  uid  (CSF) 
analysis results were within normal 
limits. Thrombocyte count returned to 
reference range after 2 days, and leu-
kocyte count improved but remained 
<3,500 cells/mm3 for 3 weeks. After 
admission to hospital, the man became 
lethargic and received noninvasive 
continuous positive airway pressure 
ventilation and treated with oseltami-
vir (150 mg 2×/d for 5 d), as well as 
with ceftriaxone, and levoﬂ  oxacin. 
Reverse transcription–PCR on a throat 
swab conﬁ  rmed  inﬂ  uenza  subtype 
H1N1 infection; blood cultures and 
urine were negative for pneumococ-
cus, and Legionella spp. antigens. In 
addition, PCR of CSF for enterovirus 
and herpesvirus had negative results. 
The patient needed respiratory support 
for 4 days, after which his mental sta-
tus and blood gases returned to refer-
ence levels. He was discharged from 
the hospital 2 weeks later. 
On day 3 after admission, a nurse 
was accidentally exposed to the pa-
tient’s urine through her eye. An 
ELISA was positive for HIV infec-
tion. Negative results for conﬁ  rmatory 
Western blot tests on days 5, 15, and 23 
showed the p24 and p41 bands; HIV 
RNA was >6 million copies/mL, CD4 
lymphocytes 51% (reference range 
29%–59%). Reverse transcription–
PCR for inﬂ  uenza subtype H1N1 per-
formed 2 months later on a stored CSF 
sample gave a negative result; PCR 
for HIV of the same sample indicated 
25,000 copies/mL. In mid-December, 
because of a further drop in CD4 lym-
phocytes to 17% (214 cells/mm3) and 
blood HIV RNA of 2.8 million copies/
mL, the patient started highly active 
antiretroviral therapy and is being fol-
lowed up as an outpatient.
Inﬂ   uenza (H1N1) and primary 
HIV infection share many signs and 
symptoms, such as fever, cough, sore 
throat, joint or limb pain, and diarrhea. 
The infections also share uncommon 
complications of the central nervous 
system (CNS); e.g., drowsiness, coma, 
and seizures. We cannot conﬁ  rm that 
CNS involvement in the patient re-
ported here was caused primarily by 
pandemic (H1N1) 2009, as suggested 
by inﬂ  uenza-like symptoms and the ap-
parent effect of oseltamivir. Nor can we 
attribute CNS involvement to primary 
infection with HIV-1 (1); CSF results 
within normal limits and PCR negative 
for inﬂ  uenza subtype H1N1 do not rule 
out a causal relationship with pandemic 
(H1N1) 2009. In fact, the few cases of 
pandemic (H1N1) 2009 encephalopa-
thy described show similar character-
istics among children and adults (2–4). 
Alternatively, some authors have at-
tributed HIV in CSF to brain inﬂ  am-
mation and damage (5,6). The severe 
leukocytopenia and thrombocytopenia 
in our patient have not been described, 
even in complicated inﬂ  uenza subtype 
H1N1 infections (7). Because lym-
phopenia and mild thrombocytopenia 
are the usual ﬁ  ndings, we believe that 
they probably resulted from HIV-1 or 
the effect of both viruses.
HIV seroconversion may initially 
occur during an acute febrile illness 
resembling inﬂ   uenza, and CNS in-
volvement can complicate both infec-
tions. During an epidemic, acute HIV 
infection should also be considered 
(8). Less frequently, as in the patient 
described above, the 2 infections can 
occur simultaneously. History of re-
cent risk behavior for blood exposure 
and severe leukocytopenia and throm-
bocytopenia should alert clinicians to 
other causes and prompt them to offer 
an HIV test to the patient. 
Enrico Barchi, Francesca Prati, 
Maria Parmeggiani, 
and Maria Luisa Tanzi
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